Drug Policy Reform Grants for 501(c)(3) Public Charity
As of July 2026, Grantoria lists 28 Drug Policy Reform Grants for 501(c)(3) Public Charity — 19 open right now, across 4 funding agencies. Award amounts range $250K to $5M. The next application deadline is July 27, 2026. All listings are free, with direct links to the official application.
The purpose of this program is to develop and implement a community-wide prevention program of drug overdose deaths by expanding access to FDA-approved opioid overdose reversal…
🏛 Substance Abuse and Mental Health Services Adminis📋 CFDA 93.490⏰ Jul 27, 2026
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants…
🏛 National Institutes of Health📋 CFDA 93.121⏰ Aug 18, 2026
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating NIH…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Sep 30, 2026
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating ICs…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Sep 30, 2026
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on Alzheimer's disease (AD) and AD-related…
🏛 National Institutes of Health📋 CFDA 93.866⏰ Oct 5, 2026
The National Institutes of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects proposing the optimization and translational development of genomic and biologic therapeutic…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Nov 10, 2026
The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or…
🏛 National Institutes of Health📋 CFDA 93.279⏰ Feb 11, 2027
The NIH Blueprint for Neuroscience Research is interested in continuing to support the BluePrint Neurotherapeutics Network for Small Molecules (BPN-SM)- a program designed to help investigators…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Jun 16, 2027
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent…
🏛 National Institutes of Health📋 CFDA 93.350⏰ Jul 2, 2027
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity…
🏛 National Institutes of Health📋 CFDA 93.121⏰ Aug 18, 2027
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027💰
up to $750,000
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027
Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally…
🏛 National Institutes of Health📋 CFDA 93.242⏰ Oct 25, 2027
Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and…
🏛 National Institutes of Health📋 CFDA 93.242⏰ Oct 25, 2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into…
🏛 National Institutes of Health📋 CFDA 93.838⏰ Dec 23, 2027
How many drug policy reform grants for 501(c)(3) public charity are available?
Grantoria currently lists 28 drug policy reform grants for 501(c)(3) public charity, of which 19 are open for applications right now. The database is refreshed daily from official federal sources (Grants.gov and SAM.gov).
When is the next deadline?
The next application deadline is July 27, 2026 — about 10 days away. Deadlines vary by program; open any grant to see its exact closing date and application window.
How much funding is available?
Award sizes range from $250K to $5M, depending on the program and applicant. Each grant shows its specific funding range where the agency has published one.
Is Grantoria free to use?
Yes — Grantoria is completely free. No account or subscription is required to browse drug policy reform grants for 501(c)(3) public charity, view deadlines and eligibility, or reach the official application.
How do I apply?
Open any grant to see its full profile — eligibility, required documents, deadlines and a direct link to the official application on the funding agency's website. You apply through the federal portal; Grantoria simply helps you find the right opportunity.
About Drug Policy Reform Grants for 501(c)(3) Public Charity
Drug policy reform grants for public charities range from $875,000 to $2.0 million in typical award sizes, with 6,403 active opportunities currently available. The National Institutes of Health, Food and Drug Administration, and Substance Abuse and Mental Health Services Administration lead funding in this space, supporting organizations working across research, pilot initiatives, and organizational capacity building.
All grants in this category use competitive application processes, giving qualified nonprofits equal access to funding regardless of geography or prior grant history. Notably, zero percent require cost-sharing, reducing financial barriers to participation. To refine your search, filter by support type—research grants and pilot funding opportunities often have distinct timelines and deliverable structures suited to different organizational stages.
